Sleep & Respiratory Newsletter
March 2018
In this issue
| |
| |
| |
| |
Clinical panel insights: addressing unmet needs in COPD treatment
A roundtable of respiratory experts convened in Boston, MA to explore how to address challenges associated with the treatment of patients with COPD. Over the course of 2018, the Philips Sleep & Respiratory Newsletter plans to revisit further some of these topics, e.g. the panel’s “guiding principles for use of nebulized Long-Acting Beta2-Agonists in COPD” formulated upon review of evidence from clinical trials and practice experience.1 The clinical luminaries covered a range of topics, including the concept of personalization when it comes to inhalation-based COPD therapy. The role of a patient’s cognitive and physical ability and poor adherence to medication2 was explored, and root causes identified.
Asthma awareness, education and solutions: Philips launches a new consumer website
67%2 of uncontrolled asthma patients think their asthma is “under control”, but studies prove otherwise.2 In fact, nearly 1 in 3 adults miss at least 1 day of work2 and nearly 1 in 2 children miss at least 1 day of school3 each year.
Awareness and information can play a key role in helping mitigate the impact asthma has on quality of life. This article profiles a new website featuring educational information to help diagnosed asthma patients effectively manage and control their condition, and debunk common myths associated with the condition.
News and topics
Philips SmartSleep at CES 2018
Upcoming events
Connect with us
Philips at ECRA/JIVD industry event 2018 More than 1500 professionals, technicians and home care suppliers are expected to attend. Philips will be showcasing some of its latest innovations in respiratory care. JIVD / 15th International Conference on home Mechanical Ventilation ERCA / 6th European Respiratory Care Association Congress March 15-18, 2018 Lyon, France
Attend our Philips symposium on March 17th, 12:00 PM “New noninvasive COPD screening of EFL with in home therapy” Chairperson: Dr. David White, Medical Director, Philips Respironics Speakers:
COPD Insider Newsletter
Register now for exclusive monthly content for COPD professionals
Sleep & Respiratory Newsletter
Want to get more sleep and respiratory articles, news and information from Philips?
Tell us what you think
Under the hood
An interview with Tom Bonnell - Head of Design, Sleep & Respiratory Care at Philips
How does think design help play a role to improve healthcare?
Great, inspiring design brings our propositions – that is the value and experience we provide to our customers and users – to life. It makes them engaging, compelling and ultimately desirable.
Great design can make those points of engagement – those everyday interactions that contribute to improving health – easier to navigate, easier to manage. And, in a sense, easier to understand in terms of what the treatment is doing physiologically to the patient, what impact is it having. Helping answer: is anything changing or improving?
Tech spotlight
InnoSpire Go FAQ patient questions
The facts, the facts and nothing but the facts. We recently profiled the new Philips InnoSpire Go portable nebulizer device. Below are a host of frequently asked questions about the technology behind the device, its capabilities and other key details. Q. How is InnoSpire Go different from a traditional jet compressor/piston nebulizer? Q. What type of drugs can I nebulize in the InnoSpire Go? Q. Can I use InnoSpire Go on board an airplane? Q. Can I use the InnoSpire Go on my child? Get these facts and more about this innovative new treatment solution
Stay up to date with CME
Access new sleep and respiratory continuing medical education on the CHEST® Journal website (CHEST links require login) in the CHEST® CME Resource Center
Available now: COPD HOT HMV: Improving Admission-Free Survival in Persistent Hypercapnic COPD
1About the study: Journal of the COPD Foundation. Published on The COPD Foundation owns the copyright to all content in the JCOPDF, unless otherwise noted. Funding for the live roundtable meeting held on August 23, 2015 in Boston, Massachusetts and medical writing support was provided by Sunovion Pharmaceuticals, Inc. Panel authors: Robert A. Wise, MD Russell A. Acevedo, MD2 Antonio R. Anzueto, MD Nicola A. Hanania, MD, MS Fernando J. Martinez, MD Jill A. Ohar, MD Donald P. Tashkin, MD. Panel authors: Robert A. Wise, MD Russell A. Acevedo, MD2 Antonio R. Anzueto, MD Nicola A. Hanania, MD, MS Fernando J. Martinez, MD Jill A. Ohar, MD Donald P. Tashkin, MD 2gsk.com. https://us.gsk.com/media/620439/the-state-of-uncontrolled-asthma-in-america-infographic.pdf. Accessed Mach 2018. 3CDC National Asthma Control Program. Asthma’s Impact on the Nation. Accessed December 2016.
